COVID-19 Drug Shortages: EU Explores Tweaking National Forecasting Models
Executive Summary
As COVID-19-related drug shortages continue to persist in the EU, regulators explore the possibility of drawing lessons from existing models that member states use to estimate national demand for medicines.
You may also be interested in...
EU Launches Fast-Track Monitoring Of Crucial COVID-19 Drug Shortages
A new system for monitoring the availability of medicines for treating COVID-19 patients will allow EU-level coordinated actions to address supply shortages in the best way.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.